MDCX (Medicus Pharma) Buyback Yield %: -103.63 (As of Jul. 04, 2026)


MDCX Medicus Pharma Ltd MDCX
13 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is Medicus Pharma Buyback Yield %?

Medicus Pharma MDCX +4.07% 13 Buyback Yield % is -103.63 as of Jul. 04, 2026. GuruFocus rates MDCX with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 292 Drug Manufacturers companies, Medicus Pharma ranks worse than 97.26% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Medicus Pharma's current buyback yield was -103.63%.

Medicus Pharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Medicus Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Pharma Buyback Yield % Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 -26.19 -47.29

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.54 -20.55 -30.66 -47.29 -133.15

MDCX vs NSRX, MIRA, SCLX: Buyback Yield % Comparison

For the Drug Manufacturers - General subindustry, Medicus Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicus Pharma Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's Buyback Yield % falls into.


MDCX
13GF Score
Medicus Pharma Ltd MDCX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Medicus Pharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 18.217) / 38.51928
=-47.29%

Medicus Pharma's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 24.443) / 18.357705
=-133.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -103.63 mean?
Medicus Pharma (MDCX) has a Buyback Yield % of -103.63 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medicus Pharma and its competitors. According to the industry distribution chart, Medicus Pharma ranks #284 out of 292 companies in the Drug Manufacturers industry, placing it in the top 97.3%.
Is Medicus Pharma's Buyback Yield % too high?
Medicus Pharma's current Buyback Yield % is -103.63. Based on the distribution chart, Medicus Pharma ranks #284 out of 292 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's Buyback Yield % compare to NSRX and MIRA?
According to the Drug Manufacturers industry distribution chart, Medicus Pharma ranks #284 out of 292 companies for Buyback Yield %. This places Medicus Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medicus Pharma and its competitors. Medicus Pharma's current Buyback Yield % is -103.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (MDCX) has a current Buyback Yield % of -103.63. The current Buyback Yield % is -103.63. Medicus Pharma's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current Buyback Yield % is -103.63 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
13GF Score

Get the complete analysis for MDCX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price